JPRN-UMIN000016875已完成未知
The effect of azilsartan medoxomil on the variability of home blood pressure and diabetic vascular complications in patients with type 2 diabetes - Azilsartan and blood pressure variability in T2DM
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are already taking azilsartan treatment Patients with aliskiren Patients with active infectious diseases, malignant diseases, severe liver dysfunction and/or renal dysfunction Pregnant women Patients who have difficulty in understanding the protocol of the present study such as dementia or unconsciousness Patients whose anti-hypertensive agents were changed within 3 months prior to enrollment
研究者
相似试验
尚未招募
1 期
Bioequivalence study of Azilsartan medoxomil 80 mg in healthy volunteer under fasting conditioBioequivalence study of Azilsartan medoxomil 80 mg in healthy volunteer under fasting conditionTCTR20240616002nison Laboratories Co., Ltd.46
已完成
3 期
Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe HypertensionHypertensionNCT00847626Takeda1,711
未知
Unknown
ALIVE studyEssential hypertensive patients with stable angina and dyslipidemiaJPRN-jRCT1080222782TAKEDA PHARMACEUTICAL COMPANY LTD.51
已完成
3 期
Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential HypertensionHypertensionNCT00591253Takeda413
未知
Unknown
A study to explore the effects of Azilsartan compared to Telmisartan on insulin resistance of patients with essential hypertension on type 2 diabetes mellitus by HOMA-R (AT-HOMA)Essential hypertension complicated by type 2 diabetes mellitusJPRN-jRCT1080222411TAKEDA PHARMACEUTICAL COMPANY LTD.40